Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Appointed director
CC transcript

Synaptogenix, Inc. (SNPX) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/01/2022 4/A WEINSTEIN ROBERT (CFO) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 75,000 options to buy @ $6.07, valued at $455.3k
12/01/2022 4/A Alkon Daniel L. (President and CSO) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 43,750 shares @ $0
12/01/2022 4/A Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 42,250 shares @ $0
12/01/2022 4/A Singer William S. (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 75,000 options to buy @ $6.07, valued at $455.3k
12/01/2022 4/A Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 75,000 options to buy @ $6.07, valued at $455.3k
12/01/2022 4/A Alkon Daniel L. (See Remark) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 75,000 options to buy @ $6.07, valued at $455.3k
12/01/2022 4/A Bernstein Bruce (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 75,000 options to buy @ $6.07, valued at $455.3k
12/01/2022 4/A TUCHMAN ALAN J (CEO) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 68,850 options to buy @ $6.07, valued at $417.9k
11/22/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
11/22/2022 8-K Quarterly results
11/18/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "Form of Certificate of Designations",
"Form of Warrant",
"Form of Purchase Agreement",
"Form of Registration Rights Agreement",
"Engagement Letter, by and between Synaptogenix, Inc. and Katalyst Securities LLC",
"Press Release"
11/17/2022 4 Bernstein Bruce (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 80,000 options to buy @ $6.07, valued at $485.6k
11/17/2022 4 Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 144,000 options to buy @ $6.07, valued at $874.1k
11/17/2022 4 WEINSTEIN ROBERT (CFO) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 96,000 options to buy @ $6.07, valued at $582.7k
11/17/2022 4 Alkon Daniel L. (See Remarks) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 112,000 options to buy @ $6.07, valued at $679.8k
11/17/2022 4 Singer William S. (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 96,000 options to buy @ $6.07, valued at $582.7k
11/17/2022 4 TUCHMAN ALAN J (CEO) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 112,000 options to buy @ $6.07, valued at $679.8k
11/17/2022 4 SCHECHTER JONATHAN (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 72,000 options to buy @ $6.07, valued at $437k
08/25/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/25/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/16/2022 8-K Quarterly results
08/05/2022 10-Q Quarterly Report for the period ended June 30, 2022
06/23/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/23/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/23/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/23/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
05/13/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/28/2022 EFFECT Form EFFECT - Notice of Effectiveness:
04/15/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
04/06/2022 4 Singer William S. (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 1,500 options to buy @ $7.41, valued at $11.1k
04/06/2022 4 Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 1,500 options to buy @ $7.41, valued at $11.1k
04/06/2022 4 SCHECHTER JONATHAN (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 1,500 options to buy @ $7.41, valued at $11.1k
04/06/2022 4 Bernstein Bruce (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 1,500 options to buy @ $7.41, valued at $11.1k
03/29/2022 10-K Annual Report for the period ended December 31, 2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy